Cargando…
Inhibition of N-type calcium ion channels by tricyclic antidepressants – experimental and theoretical justification for their use for neuropathic pain
A number of tricyclic antidepressants (TCAs) are commonly prescribed off-label for the treatment of neuropathic pain. The blockade of neuronal calcium ion channels is often invoked to partially explain the analgesic activity of TCAs, but there has been very limited experimental or theoretical eviden...
Autores principales: | Cardoso, Fernanda C., Schmit, Matthieu, Kuiper, Michael J., Lewis, Richard J., Tuck, Kellie L., Duggan, Peter J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
RSC
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8864487/ https://www.ncbi.nlm.nih.gov/pubmed/35308021 http://dx.doi.org/10.1039/d1md00331c |
Ejemplares similares
-
Antitumoral Effects of Tricyclic Antidepressants: Beyond Neuropathic Pain Treatment
por: Asensi-Cantó, Antonio, et al.
Publicado: (2022) -
Inhibition of the HERG potassium channel by the tricyclic antidepressant doxepin
por: Duncan, R.S., et al.
Publicado: (2007) -
Analysis of the analgesic effects of tricyclic antidepressants on neuropathic pain, diabetic neuropathic pain, and fibromyalgia in rat models
por: Qin, Zhenlong, et al.
Publicado: (2020) -
Tricyclic Antidepressant Structure-Related Alterations in Calcium-Dependent Inhibition and Open-Channel Block of NMDA Receptors
por: Stepanenko, Yulia D., et al.
Publicado: (2022) -
The effects of tricyclic antidepressants on breast cancer risk
por: Sharpe, C R, et al.
Publicado: (2002)